Citizens Against Government Waste America's #1 Taxpayer Watchdog

In January, Citizens Against Government Waste (CAGW) discussed a court case concerning a November 1, 2017 Centers for Medicare and Medicaid Services (CMS) final rule for Medicare Part B that will lower costs to taxpayers and Medicare beneficiaries for certain outpatient pharmaceuticals purchased under the 340B drug discount program.  It is expected the rule will save Medicare beneficiarie

On July 11 and 12, the House Ways and Means Committee marked up and passed 11 bills that will expand the use and availability of Health Savings Accounts (HSAs) for all Americans and would make other changes to the Patient Protection and Affordable Care Act (ACA), or Obamacare.  The bills considered were:

On July 12, 2018, the Federal Communications Commission (FCC) voted to adopt an Order and Notice of Proposed Rulemaking on Expanding Flexible Use of the 3.7 to 4.2 GHz Band (GN Docket No. 18-122).

Citizens Against Government Waste (CAGW) has been concerned with the 340B Drug Discount program for some time.  On June 28, 2018, the Government Accountability Office (GAO) released, “Drug Discount Program: Federal Oversight of Compliance at 340B Contract Pharmacies Needs Improvement.”  The report adds to the growing mountain of evidence that the discount program is out of control and is in dire need of restructuring.